Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation

Circulation. 1993 Sep;88(3):1101-9. doi: 10.1161/01.cir.88.3.1101.

Abstract

Background: Hypertension frequently complicates the use of cyclosporine A (CyA) therapy, and it has been suggested that sympathoexcitation may be the underlying mechanism in this form of hypertension.

Methods and results: To further investigate the possibility of a neurogenic mechanism for this hypertensive effect, we studied the effects of CyA on renal blood flow (n = 11), forearm blood flow (n = 8), and sympathetic nervous system activity, assessed by renal and whole-body radiolabeled norepinephrine plasma kinetics and muscle sympathetic nerve firing (using microneurography) in cardiac transplant recipients receiving CyA and a reference group of healthy age-matched control subjects (n = 17). In 11 cardiac transplant patients (2 hours after cyclosporine dose), renal blood flow was significantly lower than that in 8 control subjects (680 +/- 88 vs 1285 +/- 58 mL/min, P < .001). In 5 of these transplant patients, renal blood flow was measured before and for 2 hours after oral cyclosporine and fell progressively over this period, by 37% (P < .01). Total body and renal norepinephrine spillover rates in transplant patients were similar to those in control subjects (3070 +/- 538 vs 2618 +/- 313 pmol/min and 579 +/- 124 vs 573 +/- 95 pmol/min, respectively), and there was no progressive effect in the 2 hours after cyclosporine dosing. Forearm blood flow was increased 2 hours after CyA administration (1.74 +/- 0.31 to 3.12 +/- 0.50 mL x 100 mL-1 x min-1, P < .001), whereas mean arterial blood pressure and noninvasively determined cardiac output (indirect Fick method) were unchanged. Muscle sympathetic nerve discharge rates recorded in 6 of these transplant patients were not different from those in 9 healthy control subjects (37.9 +/- 10.1 vs 41.3 +/- 2.3 bursts per 100 beats per minute). During 90 to 120 minutes of recording after cyclosporine dosing, nerve firing rates remained unchanged.

Conclusions: CyA therapy causes acute renal vasoconstriction without accompanying systemic hemodynamic effects. These renal effects are nonneural, not being attributable to sympathoexcitation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclosporine / adverse effects*
  • Cyclosporine / therapeutic use
  • Female
  • Forearm / blood supply
  • Heart Transplantation*
  • Humans
  • Hypertension / chemically induced*
  • Immunosuppression Therapy*
  • Male
  • Middle Aged
  • Muscles / innervation
  • Norepinephrine / blood
  • Regional Blood Flow / drug effects
  • Renal Circulation / drug effects*
  • Sympathetic Nervous System / drug effects*
  • Sympathetic Nervous System / physiology
  • Synaptic Transmission / drug effects
  • Vascular Resistance / drug effects
  • Vasoconstriction / drug effects*

Substances

  • Cyclosporine
  • Norepinephrine